Margaret Mordin, MS

Vice President, Market Access and Outcomes Strategy

Office Location
Telecommuter - USA

MS, Public Policy
BA, Political Science
University of Rochester, Rochester, NY

Margaret Mordin, MS, is Vice President of Market Access and Outcomes Strategy at RTI-HS. Ms. Mordin has over 25 years of experience in conducting and managing outcomes research, including designing and implementing outcomes assessments in prospective trials for regulatory submission and as postmarketing studies. Her areas of expertise include study design (e.g., observational postmarketing studies, patient-reported outcomes for use in clinical development programs, and patient health-related quality of life and satisfaction surveys), analysis of outcomes data, publication development, and outcomes-related regulatory submission strategies. Her experience also includes directing health economic evaluations (prospective economic trials and billing studies).

In addition to trial-based research, Ms. Mordin’s experience encompasses all aspects of outcomes research and market access evidence generation and implementation, including health economic and outcomes strategy development, payer value proposition development and communication, market access strategy development, endpoint determination in clinical trial design, and value dossier development, leading systematic and targeted literature reviews.

Ms. Mordin has conducted outcomes research for multiple medical devices, including drug/device combination products, transdermal delivery systems, blood glucose monitoring systems, intravenous patient-controlled analgesia, multiple medication inhalation devices, photodynamic therapy, digital mammography, and knee and shoulder joint replacement implants. Ms. Mordin also has led research in the surgical setting, including arthroscopic repair for shoulder and hip surgeries.

Ms. Mordin regularly presents at conferences and has numerous publications in peer-reviewed journals, including the Journal of Managed Care Pharmacy, American Journal of Clinical Dermatology, Clinical Cardiology, Quality of Life Research, Transplantation, Oncology, and New England Journal of Medicine. Ms. Mordin's therapeutic expertise includes age-related macular degeneration, asthma, atopic dermatitis, cardiology, chronic pain, diabetes, Gaucher disease, HIV/AIDS, hyperhidrosis, kidney transplantation, oncology, ophthalmology, orthopedics, Parkinson's disease, psoriasis, and schizophrenia.

Send Margaret Mordin a message

Each document must be under 2 MB.
Maximum 3 files.
2 MB limit.
Allowed types: pdf, doc, docx, xls, xlsx, txt.

By submitting this form, you accept the RTI-HS privacy policy.